Profile of vitamin D receptor polymorphism Bsm I and FokI in end stage renal disease Egyptian patients on maintenance hemodialysis
Article Sidebar
Main Article Content
Abstract
Objective: In end stage renal disease, the synthesis of vitamin D is disturbed.Hyperparathyroidism is one of the key factors in the pathogenesis of many of the complications of dialysis mainly bone and cardiovascular complications.Aim:This study aimed at assessing vitamin D receptor gene polymorphisms BsmIand FokI in Egyptian patients with end stage renal disease on maintenance haemodialysis and the assosciation of these polymorphisms with cardiovascular complications and hyperparathyroidism among these patients.
Methods: One hundred subjects, recruited from Medical Research Institute, from March to July 2014, divided into two main groups; the control group which included thirty apparently healthy subjects and the patients group which included seventy patients with end stage renal disease on maintenance haemodialysis with median 4 years. To all studied subjects, detailed history was taken, thorough physical examination, carotid intima media thickness, presence of plaques and ECG ischemic changes. Laboratory investigations included serum levels of: glucouse, urea, creatinine, uric acid, albumin, total cholesterol, low and high density lipoproteins, calcium, phosphorus, and CRP as well as plasma PTH level. For molecular studies, the detection of BsmI and FokI polymorphisms using polymerase chain reaction and restriction fragment length polymorphism (PCR / RFLP) technique.
Results: 1.No statistically significant difference could be detected in both BsmI and FokI gene polymorphisms between the hemodialysis patients and the controls, suggesting that the development of ESRD had no relation with either VDR BsmI or FokI gene polymorphisms.2.No statistically significant difference were found in these polymorphisms between the hemodialysis patients with or without cardiovascular complications or between patients with PTH level less or more than 300 pg/ml. These results suggest that the development of cardiovascular complications and secondary hyperparathyroidism among Egyptian patients on maintenance haemodialysis cannot be attributed to these two gene polymorphisms.
Conclusion: No association could be found between the variant alleles of BsmI and FokI gene polymorphisms and the development of ESRD, cardiovascular complications and secondary hyperparathyroidism among the studied samples of Egyptian patients on maintenance haemodialysis.
Article Details
Copyright (c) 2017 EL-Attar HA, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Clinical Nephrology is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Clinical Nephrology is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Tang J. Vitamin D and its role in chronic kidney disease. Nephrology Rounds. 2009; 7: 1-6.
Feldman D, Pike JW, Adams JS. Vitamin D, 3rd Ed. Academic Press Elsevier, Amsterdam. 2011; 1245-90.
Hollick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266-2681. Ref.: https://goo.gl/6ioGRP
Grzegorzewska AE, Świderska MK, Mostowska A, Warchoł W, Jagodziński PP. Polymorphisms of vitamin D receptorsignaling pathway genes and calcium-sensing receptor gene in respect to survival of hemodialysis patients: A prospective observational study. Int J Endocrinol. 2016; 2383216: 11. Ref.: https://goo.gl/Vm7YAc
Kato S. The function of vitamin D receptor in vitamin D action. J Biochem. 2000; 127: 717-722. Ref.: https://goo.gl/2UKFNz
Thorne J, Campbell MJ. The vitamin D receptor in cancer. Proc Nutr Soc. 2008; 67: 115-127. Ref.: https://goo.gl/PNpRJL
Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004; 80: 1678-1688. Ref.: https://goo.gl/MDQHxA
Germain P, Staels B, Dacquet C, Spedding M, Laudet V. Overview of nomenclature of nuclear receptors. Pharmacol Rev. 2006; 58: 685-704. Ref.: https://goo.gl/jQsXra
Genetics home reference. http://ghr.nlm.nih.gov/gene/VDR.
Bouillon R, Carmeliet G, Verlinden L, Van Etten E, Verstuyf A, et al. Vitamin D and Human Health: Lessons from vitamin D receptornull mice. Endocr Rev. 2008; 29: 726-776. Ref.: https://goo.gl/mZMxYS
Valdivielso JM, Fernandez E. Vitamin D receptor polymorphism and disease. Clin Chim Acta. 2006; 371: 1-12. Ref.: https://goo.gl/4Tvt1s
Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L. Natural selection has driven population differentiation in modern humans. Nat Genet. 2008; 40: 340-345. Ref.: https://goo.gl/6V16kH
Bid HK, Mittal RD. Study of vitamin-D receptor (VDR) gene start codon polymorphism (Fok I) in healthy individuals from North India. Indian J Hum Genet. 2003; 9: 51-4.
Li WH, Gu Z, Wang H, Nekrutenko A. Evolutionary analyses of the human genome. Nature 2001; 409: 847-849. Ref.: https://goo.gl/jE2BEY
Uitterlinden AG, Fang Y, van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338: 143-156. Ref.: https://goo.gl/mtd2hs
Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev. 2000; 22: 203-217. Ref.: https://goo.gl/nRPwNd
http://www.snpedia.com/index.php/Rs1544410
Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, et al. Functionally relevant polymorphisms in the human nuclear vitamin Dreceptor gene. Mol Cell Endocrinol. 2001; 177: 145-1459. Ref.: https://goo.gl/VdS6vT
http://www.snpedia.com/index.php/Rs2228570
Mosos I, Marginean O. Links between vitamin Ddeficiency and cardiovascular diseases. Biomed Res Int. 2015; 109275: 12. Ref.: https://goo.gl/9puMuk
Nigwekar SU, Tamez H, Thadhani RI. Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD). Bonekey Rep. 2014; 3: 498. Ref.: https://goo.gl/853Fi
Tomasello S. Secondary hyperparathyroidism and chronic kidney disease. Diabetes Spectrum 2008; 21: 19-25.
Santoro D, Lucisano S, Gagliostro G, Alibrandi A, Benvenga S, et al. Vitamin D receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease. J Ren Nutr. 2015; 25: 187-193. Ref.: https://goo.gl/JDdtPo
Fernandez Fernández E, Fibla J, Betriu A, Piulats JM, Almirall J, et al. Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol. 1997; 8: 1546-1552. Ref.: https://goo.gl/LGJ3XU
Vigo GE, Cadarso-Suarez C, Perez-Fernandez R, Romero BR, Devesa MJ, et al. Association between vitamin D receptor FokI Polymorphism and serum parathyroid hormone level in patients with chronic renal failure. J Endocrinol Invest. 2005; 28: 117-121. Ref.: https://goo.gl/nSpKAD
Yildiz A, Tepe S, Olfaz H, Yazici H, Ark E, et al. Carotid atherosclerosis is a predictor of coronary calcification in chronic hemodialysis patients. Nephrol Dial Transplant. 2004; 19: 885-891. Ref.: https://goo.gl/cQV5ic
Ruiz MR, Cajavilca C, Varon J. Einthoven's string galvanometer the first electrocardiograph. Tex Heart Inst J. 2008; 35: 174-178. Ref.: https://goo.gl/QpEFcC
Burtis CA, Ashwood ER, Bruns DE. Tietz Text Book of Clinical Chemistry and Molecular Diagnostics. 4th Ed. Elsevier Saunders Company, St Louis. 2006; 1689-1699.
Gunes S, Sumer AP, Keles GC, Kara N, Koprulu H, et al. Analysis of vitamin D receptor gene polymorphisms in patients with chronic periodontitis. Indian J Med Res. 2008; 127: 58-64. Ref.: https://goo.gl/RUuhpf
Mansour L, Sedky M, AbdelKhader M, Sabry R, Kamal M, et al. The role of vitamin D receptor genes (FOKI and BSMI) polymorphism in osteoporosis. Middle East Fertil Soc J. 2010; 15: 79-83.
Daly LE, Bourke GJ. Interpretation and uses of medical statistics. 5th Ed. Blackwell Science, Oxford, Malden. 2000.
Puri BK. SPSS in practice: an illustrated guide. 2nd Ed. Arnold, London, New York. 2002.
Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006; 65: 33-43. Ref.: https://goo.gl/qJpaVV
Kumar P, Clark M. Kumar and Clark's Clinical Medicine. 7th Ed. Elsevier Saunders Company, Edinburgh, 2009; 628.
Ozdemir FN, Sezer S, Atac B, Tutal E, Verdi H, et al. Vitamin D receptor BsmI and TagI gene polymorphisms in a Turkish ESRD population: influences on parathyroid hormone response. Transplant Proc. 2005; 37: 2922-2924. Ref.: https://goo.gl/JPJepx
El Gawad SS, Samea ER, Sherif M, Elrakhawy MM. Vitamin D receptor genotypes, bone mineral density and biochemical markers of bone turnover in Egyptian premenopausal women with graves ' disease. New York Science Journal. 2012; 5: 54-61.
Mostowska A, Lianeri M, Wudarski W, Olesińska M, Jagodziński PP. Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep. 2013; 40: 803-810. Ref.: https://goo.gl/EQBP9w
Paul J, Dasgupta S, Ghosh MK. Carotid artery intima media thickness as a surrogate marker of atherosclerosis in patient with chronic renal failure on hemodialysis. N Am J Med Sci. 2012; 4: 77-80. Ref.: https://goo.gl/xBx8HS
Rahman M, Smith MC. Hypertension in hemodialysis patients. Curr Hypertens Rep. 2001; 3: 496-502. Ref.: https://goo.gl/4FHxRf
Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003; 115: 291-297. Ref.: https://goo.gl/BoHgR3
Agarwal R. Hypertension and survival in chronic hemodialysis patients-past lessons and future opportunities. Kidney Int. 2005; 67: 1-13. Ref.: https://goo.gl/ZoNdVG
Stidley CA, Hunt WC, Tentori F, Schmidt D, Rohrscheib M, et al. Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol 2006; 17: 513-20. Ref.: https://goo.gl/ADveVN
Pan XM, Li DR, Yang L, Wang EY, Chen TY, et al. No association between vitamin D receptor polymorphisms and coronary artery disease in a Chinese population. DNA Cell Biol 2009; 28: 521-525. Ref.: https://goo.gl/AE6sKT
Ortlepp JR, Von Korff A, Hanrath P, Zerres K, Hoffmann R. Vitamin D receptor gene polymorphism BsmI is not associated with the prevalence and severity of CAD in a large-scale angiographic cohort of 3441 patients. Eur J Clin Invest. 2003; 33: 106-109. Ref.: https://goo.gl/EdWStv
Yokoyama K, Nakashima A, Urashima M, Suga H, Mimura T, et al. Interactions between serum vitamin D levels and vitamin D receptor gene FokI polymorphisms for renal function in patients with type 2 Diabetes. PLoS One. 2012; 7: 16. Ref.: https://goo.gl/DHrnqj
Baravkar PN, Bavikar JS, Asegaonkar SB, Bavikar SS, Bardapurkar JS, et al. Study of serum uric acid and C-reactive protein levels in patients with chronic renal disease. Int J Biol Med Res. 2013; 4: 2758-2761.
Horl WH. The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes. Nephrol Dial Transplant. 2004; 19: 2-8. Ref.: https://goo.gl/k7FkdF
Tagliabue J, Farina M, Imbasciati E, Vergani C, Annoni G. BsmI polymorphism of the vitamin D receptor gene in hyperparathyroid or hypoparathyroid dialysis patients. Am J Clin Pathol. 1999; 112: 366-370. Ref.: https://goo.gl/q9eGr3
Nagaba Y, Heishi M, Tazawa H, Tsukamoto Y, Kobayashi Y. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients. Am J Kidney Dis 1998; 32: 464-469. Ref.: https://goo.gl/eLjFSy
Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S, et al. Vitamin-D-receptor genotypes in primary hyperparathyroidism. Nat Med 1995; 1: 1309-1311. Ref.: https://goo.gl/C83PL2
Tsukamoto Y, Heishi M, Nagaba Y, Kobayashi N, Nomura Y, et al. More on hyperparathyroidism and the vitamin D receptor. Nat Med. 1996; 2: 1162. Ref.: https://goo.gl/MXmztE
Valdivielso JM, Fernandez E. Vitamin D receptor polymorphism and disease. Clin Chim Acta. 2006; 371: 1-12. Ref.: https://goo.gl/6nh7yN
Giannini S, D'Angelo A, Nobile M, Carraro G, Rigotti P, et al. The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation. J Bone Miner Res. 2002; 17: 1768-1773. Ref.: https://goo.gl/vjM6Lz
Falkiewicz K, Bidzinska B, Demissie M, Boratyńska M, Zmonarski SC, et al. Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation. Transplant Proc. 2005; 37: 1023-1025. Ref.: https://goo.gl/TXpce2
Uitterlinden AG, Fang Y, van Meurs JB, Pols HA, van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338: 143-1456. Ref.: https://goo.gl/wYBjkt